Stay updated on Nivolumab in Resected Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Resected Esophageal Cancer Clinical Trial page.

Latest updates to the Nivolumab in Resected Esophageal Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded the NEJM 2021 CheckMate 577 publication citation; removed the Erratum reference.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedA new revision label v3.4.2 was added to the study documents, replacing the previous v3.4.1.SummaryDifference0.0%

- Check38 days agoChange DetectedAdded the CheckMate 577 NEJM publication entry with full author list and erratum citation; removed the previous NEJM entry and updated the revision from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check52 days agoChange DetectedAdded new metadata/UI elements including a glossary toggle, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and revision v3.4.0. Removed older metadata fields: Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and revision v3.3.4.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed.SummaryDifference0.0%

- Check88 days agoChange DetectedThe page now lists a broader set of study locations across multiple countries and regions, expanding the geographic coverage of sites. Some locations have been reorganized or removed.SummaryDifference3%

Stay in the know with updates to Nivolumab in Resected Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Resected Esophageal Cancer Clinical Trial page.